Teva Pharmaceutical Industries Limited (TEVA) News Headlines

▮ More

Date

Headline

12/26/2018 7:36:57 AM Neos Reaches Settlement With Teva On Cotempla XR-ODT Patent Litigation

12/22/2018 12:51:18 PM Teva Announces FDA Approval Of Inhaler With Built-In Sensors

12/22/2018 11:53:30 AM Teva Pharma: FDA Approves ProAir Digihaler Inhalation Powder

12/17/2018 8:08:42 AM Teva Reports Positive Topline Phase IIIb Results With Fremanezumab - Quick Facts

12/17/2018 8:02:39 AM Teva Says FOCUS Study On Fremanezumab Met All Primary And Secondary Endpoints

12/5/2018 6:00:52 AM Citi Says Appointed As Successor Depositary Bank For Teva’s ADR Programme

11/1/2018 12:27:37 PM Teva Pharmaceutical Sharply Higher On Upbeat Q3 Results, Guidance

11/1/2018 7:19:19 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 Revenue Estimate To $18.6 - $19.0 Bln From $18.5 - $19.0 Bln

11/1/2018 7:18:40 AM Teva Pharmaceutical Industries Limited (TEVA) Has Raised Its FY18 EPS Estimate To 2.80 - 2.95 From 2.55 - 2.80

11/1/2018 7:17:41 AM Teva Pharmaceutical Industries Limited Q3 adjusted earnings Beat Estimates

11/1/2018 7:13:17 AM Teva Pharmaceutical Raises FY18 Adj. Earnings Outlook - Quick Facts

11/1/2018 7:01:29 AM Teva Q3 GAAP Loss Per Share Of $0.27; Non-GAAP EPS $0.68

11/1/2018 7:01:28 AM Teva Pharmaceutical Q3 18 Earnings Conference Call At 8:00 AM ET

10/21/2018 9:39:58 AM Teva To Establish North America Headquarters In Parsippany-Troy Hills

10/17/2018 12:51:56 PM Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off

10/14/2018 10:29:34 PM FDA Panel Backs ACRX's Pain Drug, ALL Eyes On EARS, TNDM On Watch

10/11/2018 5:01:13 AM Teva Draws On Patient Experience To Empower Those Living With Chronic Conditions

10/10/2018 11:02:50 AM Teva Presents 25-year Safety Data From Longest Continuous Trial Of COPAXONE For Treatment Of RMS

10/9/2018 9:02:58 AM Celmatix Enters Partnership To Bring The Fertilome Genetic Test To Israel

10/8/2018 7:02:54 AM Teva To Present New Data At 34th European Committee For Treatment And Research In Multiple Sclerosis Congress In Berlin